Creating a comprehensive treatment plan for hereditary angioedema

Marc A Riedl

doi:10.1016/j.iac.2013.07.003

Creating a comprehensive treatment plan for hereditary angioedema

Immunol Allergy Clin North Am. 2013 Nov;33(4):471-85. doi: 10.1016/j.iac.2013.07.003. Epub 2013 Aug 26.

Author

Marc A Riedl¹

Affiliation

¹ Division of Rheumatology, Allergy and Immunology, University of California - San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA. Electronic address: [email protected].

PMID: 24176212
DOI: 10.1016/j.iac.2013.07.003

Abstract

Management of hereditary angioedema (HAE) has changed dramatically in recent years because of the availability of several HAE-specific medications. This paradigm shift in therapy provides the opportunity to dramatically improve the care of HAE patients, but has increased the complexity of treatment. Patient education and communication with health care providers is crucial. Early treatment of HAE attacks has been shown to improve clinical outcomes, highlighting the importance of rapid and reliable treatment. This review summarizes the current evidence for best practices in HAE management, and suggests practical steps toward developing a comprehensive treatment plan.

Keywords: C1INH deficiency; Hereditary angioedema; Therapy; Treatment plan.

Publication types

Review

MeSH terms

Angioedemas, Hereditary / prevention & control
Angioedemas, Hereditary / therapy*
Counseling
Disease Management*
Follow-Up Studies
Humans
Patient Education as Topic